5 Nov 2022 , 04:10 PM
Net profit of Rossari Biotech declined 8.81% to Rs 23.92 crore in the quarter ended September 2022 as against Rs 26.23 crore during the previous quarter ended September 2021. Sales rose 10.64% to Rs 425.44 crore in the quarter ended September 2022 as against Rs 384.52 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 425.44 | 384.52 | 11 |
| OPM % | 13.29 | 11.84 | – |
| PBDT | 49.26 | 46.00 | 7 |
| PBT | 33.62 | 35.81 | -6 |
| NP | 23.92 | 26.23 | -9 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
